The PE Ratio as of December 2024 (TTM) for IDEAYA Biosciences, Inc. (IDYA) is -10.89

According to IDEAYA Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.89. This represents a change of -31.62% compared to the average of -15.93 of the last 4 quarters.

IDEAYA Biosciences, Inc. (IDYA) Historical PE Ratio (quarterly & annually)

How has IDYA PE Ratio performed in the past?

The mean historical PE Ratio of IDEAYA Biosciences, Inc. over the last ten years is -11.73. The current -10.89 PE Ratio has changed 9.18% with respect to the historical average. Over the past ten years (40 quarters), IDYA's PE Ratio was at its highest in in the September 2022 quarter at 58.49. The PE Ratio was at its lowest in in the March 2021 quarter at -20.68.

IDEAYA Biosciences, Inc. (IDYA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of IDEAYA Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IDEAYA Biosciences, Inc. (IDYA) Average PE Ratio

How has IDYA PE Ratio performed in the past?

The current PE Ratio of IDEAYA Biosciences, Inc. (IDYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IDEAYA Biosciences, Inc. (IDYA) PE Ratio vs. Peers

How is IDYA’s PE Ratio compared to its peers?

IDEAYA Biosciences, Inc.’s PE Ratio is less than AnaptysBio, Inc. (-2.44), less than MeiraGTx Holdings plc (-4.95), less than Keros Therapeutics, Inc. (-3.40), less than Homology Medicines, Inc. (-0.01), less than Ventyx Biosciences, Inc. (-1.09), less than Protagonist Therapeutics, Inc. (14.68), greater than Verona Pharma plc (-23.97), less than Syndax Pharmaceuticals, Inc. (-3.83), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), greater than Avidity Biosciences, Inc. (-13.92), greater than Revolution Medicines, Inc. (-12.93), greater than Day One Biopharmaceuticals, Inc. (-14.55), less than SpringWorks Therapeutics, Inc. (-10.09), less than Terns Pharmaceuticals, Inc. (-5.24), less than Acumen Pharmaceuticals, Inc. (-1.30), less than Amylyx Pharmaceuticals, Inc. (-1.07), greater than MoonLake Immunotherapeutics (-40.60), less than X4 Pharmaceuticals, Inc. (-6.92), less than Inozyme Pharma, Inc. (-1.97), less than VectivBio Holding AG (-7.94),

Build a custom stock screener for IDEAYA Biosciences, Inc. (IDYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IDEAYA Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IDEAYA Biosciences, Inc. (IDYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IDEAYA Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.